Generation Bio Co.
GBIOUnlisted companyGeneration Bio Co. in brief
Generation Bio Co. is an unlisted company in the Biotechnology industry, based in Massachusetts, USA. In the year to Dec 2020 it had sales of $0 M and a net loss of $80 M. It employs about 85 people.
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
About Generation Bio Co.
Generation Bio is a Genetic Medicine and Healthcare company. It is having 103 employees as on 2019. The headquarters is in USA.
Generation Bio Co. timeline
- 2020
- 🔔· approximateInitial public offering on Nasdaq
Events of Generation Bio Co. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Generation Bio Co.
- Acquisitions and changes
- No longer listed: ticker GBIO is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #1,942 (Jan 2021) · #3,204 (Jan 2022) · #3,451 (Dec 2022) · #3,077 (Jul 2023) · #3,546 (Jan 2024)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-81 M
Dec-2020 ending year
Markets and events: Generation Bio Co.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2026-02-07 00:50 UTC, code D, resumed 05:00 UTC
- 2025-12-15 21:55 UTC, code T3, resumed 22:30 UTC
- 2025-07-21 23:50 UTC, code T3, resumed 13:00 UTC
Fails to deliver
- : 1 shares at $5.34
- : 654 shares at $5.64
- : 2,597 shares at $5.48
- : 658 shares at $5.38
- : 36 shares at $5.40
H-1B hiring at Generation Bio Co.#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $94 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Senior Associate Scientist, Bioconjugation Delivery ResearchMedical Scientists, Except Epidemiologists | 1 | $94 K |
Where: Cambridge, MA 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $94 K | 1 |
| FY2025 | 2 | 2 | $168 K | 2 |
| FY2024 | 2 | 2 | $168 K | 2 |
| FY2023 | 5 | 5 | $94 K | 6 |
| FY2022 | 1 | 1 | $80 K | 1 |
| FY2021 | 6 | 6 | $90 K | 6 |
How Generation Bio Co. compares in Biotechnology
- Revenue$0 M · higher than 0% of 648
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Generation Bio Co.🇺🇸 | $126 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
How current the figures are
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Employees:
- As on April-2020
- Profile updated:
- Nov 14, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Generation Bio Co.? Verify and update this profile — free
Show Generation Bio Co.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.